|
|
| | Xopenex HFA Basic information |
| Product Name: | Xopenex HFA | | Synonyms: | (alpha1R)-alpha1-(((1,1-Dimethylethyl)amino)methyl)-4-hydroxy-1,3-benzenedimethanol (2R,3R)-2,3-dihydroxybutanedioate (2:1);Levosalbutamol tartrate;Xopenex HFA;(R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxy-methyl)phenol (2R,3R)-2,3-dihydroxysuccinat;(R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxy-methyl)phenol (2R,3R)-2,3-dihydroxysucci;Levalbuterol tartrate
(Levosalbutamol tartrate);Xopenex HFA USP/EP/BP;(R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxy-methyl)phenol (2R,3R)-2,3-dihydroxysuccinate | | CAS: | 661464-94-4 | | MF: | C17H27NO9 | | MW: | 389.39758 | | EINECS: | | | Product Categories: | | | Mol File: | 661464-94-4.mol |  |
| | Xopenex HFA Chemical Properties |
| storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Powder | | CAS DataBase Reference | 661464-94-4 |
| | Xopenex HFA Usage And Synthesis |
| Uses | Anti-asthmatic and bronchodilator( 2-adrenergic receptor agonist). | | Brand name | Xopenex (Sepracor). | | IC 50 | β adrenergic receptor |
| | Xopenex HFA Preparation Products And Raw materials |
|